Abstract:BACKGROUND:The Cancer Genome Atlas (TCGA) has generated comprehensive molecular profiles. We aim to identify a set of genes whose expression patterns can distinguish diverse tumor types. Those features may serve as biomarkers for tumor diagnosis and drug development.METHODS:Using RNA-seq expression data, we undertook a pan-cancer classification of 9,096 TCGA tumor samples representing 31 tumor types. We randomly assigned 75% of samples into training and 25% into testing, proportionally allocating samples from each tumor type.RESULTS:We could correctly classify more than 90% of the test set samples. Accuracies were high for all but three of the 31 tumor types, in particular, for READ (rectum adenocarcinoma) which was largely indistinguishable from COAD (colon adenocarcinoma). We also carried out pan-cancer classification, separately for males and females, on 23 sex non-specific tumor types (those unrelated to reproductive organs). Results from these gender-specific analyses largely recapitulated results when gender was ignored. Remarkably, more than 80% of the 100 most discriminative genes selected from each gender separately overlapped. Genes that were differentially expressed between genders included BNC1, FAT2, FOXA1, and HOXA11. FOXA1 has been shown to play a role for sexual dimorphism in liver cancer. The differentially discriminative genes we identified might be important for the gender differences in tumor incidence and survival.CONCLUSIONS:We were able to identify many sets of 20 genes that could correctly classify more than 90% of the samples from 31 different tumor types using TCGA RNA-seq data. This accuracy is remarkable given the number of the tumor types and the total number of samples involved. We achieved similar results when we analyzed 23 non-sex-specific tumor types separately for males and females. We regard the frequency with which a gene appeared in those sets as measuring its importance for tumor classification. One third of the 50 most frequently appearing genes were pseudogenes; the degree of enrichment may be indicative of their importance in tumor classification. Lastly, we identified a few genes that might play a role in sexual dimorphism in certain cancers.

Remarkable Difference of Somatic Mutation Patterns Between Oncogenes and Tumor Suppressor Genes.

Identify Cancer Survival Related Mutation Genes from Integrated TCGA Datasets

Characterization of tumor suppressors and oncogenes evaluated from TCGA cancers

Genome-wide Mutational Spectra Analysis Reveals Significant Cancer-Specific Heterogeneity

A Network Of Cancer Genes With Co-Occurring And Anti-Co-Occurring Mutations

Nucleotide-Based Significance of Somatic Synonymous Mutations for Pan-Cancer

Identifying Candidate Cancer Genes Based on Their Somatic Mutations Co-Occurring with Cancer Genes in Cancer Genome Profiling

Mutation-Profile-Based Methods for Understanding Selection Forces in Cancer Somatic Mutations: A Comparative Analysis

Somatic Gene Mutation Signatures Predict Cancer Type and Prognosis in Multiple Cancers with Pan-Cancer 1000 Gene Panel.

Identifying Candidate Cancer Genes by Finding Co-Occurring Mutations in Cancer Mutation Profiles

An Analysis of Mutational Signatures of Synonymous Mutations Across 15 Cancer Types.

Mutational landscape and significance across 12 major cancer types

Distinct Patterns of Somatic Alterations in a Lymphoblastoid and a Tumor Genome Derived from the Same Individual.

Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

A comparison analysis of the somatic mutations in early-onset gastric cancer and traditional gastric cancer

Genomics Alterations of Metastatic and Primary Tissues Across 15 Cancer Types

A Comparative Study of Genetic Profiles of Key Oncogenesis-Related Genes Between Primary Lesions and Matched Lymph Nodes Metastasis in Lung Cancer

The Discordance of Gene Mutations between Circulating Tumor Cells and Primary/Metastatic Tumor.

A Comprehensive Genomic Pan-Cancer Classification Using the Cancer Genome Atlas Gene Expression Data.

The Discordance of Gene Mutations Between Circulating Tumor Cells and Primary/Metastatic Tumor

Comprehensive Analysis of Co-Mutations Identifies Cooperating Mechanisms of Tumorigenesis